Home> Products> immediate release formulations

{ "products": [ { "_id": "6790bd2262059c5632ce4d2d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Magnesium Valproate 200mg", "description": "VALPOTREAT MAG 200 is a specially formulated medication containing Magnesium Valproate in a controlled-release tablet. It is widely prescribed to manage and control various neurological conditions such as epilepsy and bipolar disorder. Designed for effective absorption and consistent therapeutic effects, this medication helps stabilize mood and prevent seizures, improving the quality of life for those dealing with these conditions.\n\n \nKey Benefits:\n \n\nSeizure Control: Effective in preventing and managing various types of seizures, including absence seizures, generalized tonic-clonic seizures, and complex partial seizures.\nMood Stabilization: Provides relief from mood swings and supports emotional balance in patients with bipolar disorder.\nControlled Release: Ensures gradual absorption, reducing fluctuations in drug levels and minimizing side effects.\nNeurological Support: Enhances brain health and stabilizes nerve impulses, making it an essential treatment for epilepsy and related conditions.\nBetter Tolerability: The addition of magnesium reduces gastrointestinal discomfort, often associated with other valproate formulations.\n \nHow Does It Work?\n \n\nMagnesium Valproate works by increasing the availability of gamma-aminobutyric acid (GABA), a neurotransmitter in the brain that calms nerve activity. By stabilizing neuronal firing, it prevents excessive electrical discharges that lead to seizures. Additionally, it balances neurotransmitters involved in mood regulation, making it effective for managing bipolar disorder. The controlled-release formulation ensures consistent drug levels, offering prolonged symptom control while minimizing side effects.\n\n \nDirections for Use:\n \n\nDosage: Take the dose as prescribed by your healthcare provider, usually once or twice daily.\nWith Food: To minimize gastrointestinal irritation, take the tablet with or after meals.\nSwallow Whole: Do not crush or chew the tablet to preserve the controlled-release properties.\nConsistency: Take the medication at the same time each day for optimal effectiveness.\nMissed Dose: If a dose is missed, take it as soon as you remember. Skip the missed dose if it’s close to the next scheduled dose.\n \nSide Effects:\n \n\nWhile VALPOTREAT MAG 200 is generally well-tolerated, some individuals may experience mild to moderate side effects, including:\n\nCommon Side Effects: Nausea, vomiting, dizziness, drowsiness, and abdominal discomfort.\nRare Side Effects: Tremors, weight changes, hair loss, and temporary changes in liver enzyme levels.\nSevere Reactions: In rare cases, severe allergic reactions, unusual bleeding, or behavioral changes may occur. If these symptoms arise, seek immediate medical attention.", "price": 78.0, "discountamount": 24.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "missed dose", "effective absorption", "widely prescribed", "controlledrelease tablet", "medical attention", "hair loss", "experience mild", "generally welltolerated", "valpotreat mag 200", "remember skip", "meals swallow", "healthcare provider", "seizures additionally", "valproate formulations", "related conditions", "essential treatment", "drug levels", "neurological conditions", "magnesium valproate", "mood swings", "managing bipolar disorder", "prevent seizures improving", "specially formulated medication", "controlledrelease properties consistency", "mood regulation making", "symptoms arise seek", "moderate side effects", "minimize gastrointestinal irritation", "balances neurotransmitters involved", "stabilizing neuronal firing", "calms nerve activity", "gammaaminobutyric acid gaba", "supports emotional balance", "consistent therapeutic effects", "bipolar disorder designed" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2035, "imageuri": "https://productimages.withfloats.com/actual/6790bd322323937ff0a17443.png", "tileimageuri": "https://productimages.withfloats.com/tile/6790bd322323937ff0a17443.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-01-22T09:40:50.336Z", "updatedon": "2025-01-22T09:40:50.336Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/magnesium-valproate-200mg/2035", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT MAG 200 ", "category": "neurology", "tags": [ "Magnesium valproate vs sodium valproate", "Magnesium valproate prolonged release tablets", "Magnesium valproate Wikipedia", "Magnesium valproate side effects", "Magnesium valproate Brand Name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66643724db9fdd21801f1af0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MESALMILE 800 ER ", "description": "MESALMILE 800 ER \nMesalamine (800mg)\nMESALMILE 800 ER is a medication that contains Mesalamine in an extended-release (ER) formulation, with each tablet containing 800mg of Mesalamine. Mesalamine belongs to a class of medications known as aminosalicylates, which are used to treat various inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.\n\nMesalamine works by reducing inflammation in the colon and rectum. It is believed to inhibit the production of inflammatory chemicals in the body, thus helping to alleviate symptoms such as abdominal pain, diarrhea, and rectal bleeding that are common in inflammatory bowel diseases.\n\nThe extended-release formulation of MESALMILE 800 ER allows for a gradual release of Mesalamine throughout the day, providing sustained relief from symptoms and reducing the frequency of dosing compared to immediate-release formulations.\n\nIt is important to take MESALMILE 800 ER as prescribed by your healthcare provider. Dosage and duration of treatment may vary depending on the severity of your condition and your individual response to the medication. Regular monitoring and follow-up with your healthcare provider are essential to ensure the effectiveness and safety of treatment.\n\nCommon side effects of Mesalamine may include nausea, vomiting, diarrhea, abdominal pain, and headache. Serious side effects such as allergic reactions or worsening of symptoms should be reported to your healthcare provider immediately.\n\nMESALMILE 800 ER is a valuable medication for managing inflammatory bowel diseases, but it should be used under the guidance and supervision of a healthcare professional to optimize its benefits and minimize potential risks.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mesalmile-800-er-133781\n\n\n\n\n\n\n", "price": 260.0, "discountamount": 78.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Call", "ORDER", "Email", "colon", "Crohn", "class", "800mg", "dosing", "tablet", "Dosage", "safety", "rectum", "nausea", "symptoms", "severity", "diarrhea", "duration", "vomiting", "WhatsApp", "headache", "guidance", "benefits", "follow-up", "frequency", "treatment", "worsening", "condition", "production", "Mesalamine", "information", "supervision", "medications", "sterispharma", "sterisonline", "inflammation", "effectiveness", "abdominal pain", "rectal bleeding", "potential risks", "gradual release", "aminosalicylates", "sustained relief", "MESALMILE 800 ER", "allergic reactions", "ulcerative colitis", "Regular monitoring", "individual response", "healthcare provider", "valuable medication", "Common side effects", "Serious side effects", "inflammatory chemicals", "healthcare professional", "extended-release formulation", "immediate-release formulations", "extended-release (ER) formulation", "various inflammatory bowel diseases" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1578, "imageuri": "https://productimages.withfloats.com/actual/66643727cb17fd7b0aaa1e3d.png", "tileimageuri": "https://productimages.withfloats.com/tile/66643727cb17fd7b0aaa1e3d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T10:49:08.066Z", "updatedon": "2024-06-28T09:18:38.816Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mesalmile-800-er-/1578", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MESALMILE 800 ER ", "category": "GASTROLOGYRANGE", "tags": [ "MESALMILE 800 ER", "Mesalamine 800mg uses", "Mesalamine (800mg)", "Mesalamine 800mg dosage", "Mesalamine 800mg side effects", "Mesalamine 800mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666435a84515df17486247f1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MESALMILE 400", "description": "MESALMILE 400\nMesalamine ER (400mg)\nMESALMILE 400 is a medication containing Mesalamine ER (extended-release) in a 400mg dosage. Mesalamine is a type of anti-inflammatory drug used to treat inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease. The extended-release formulation ensures a gradual and sustained release of the medication, providing consistent therapeutic effects.\n\nMesalamine works by reducing inflammation in the digestive tract, specifically targeting the lining of the colon. It helps to alleviate symptoms such as abdominal pain, diarrhea, rectal bleeding, and urgency to have a bowel movement, which are common in ulcerative colitis and Crohn's disease.\n\nThe extended-release formulation of Mesalamine allows for less frequent dosing, often once daily, compared to immediate-release formulations that may require multiple doses throughout the day. This convenience can improve medication adherence and patient compliance.\n\nIt is important to follow the prescribed dosage and administration instructions provided by your healthcare provider when using MESALMILE 400. Regular monitoring and follow-up appointments may be necessary to assess the effectiveness of the medication and manage any potential side effects.\n\nCommon side effects of Mesalamine may include nausea, vomiting, diarrhea, abdominal pain, headache, and rash. Serious side effects such as allergic reactions or worsening of certain conditions may occur but are rare. It is essential to report any unusual or severe symptoms to your healthcare provider promptly.\n\nMESALMILE 400 with Mesalamine ER (400mg) is an effective medication for managing inflammatory bowel diseases and improving the quality of life for patients experiencing symptoms related to these conditions.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mesalmile-400-133779\n\n\n\n\n\n\n", "price": 88.0, "discountamount": 27.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "IBD", "day", "life", "rash", "type", "ORDER", "Crohn", "Email", "colon", "lining", "nausea", "gradual", "quality", "unusual", "urgency", "diarrhea", "vomiting", "headache", "patients", "WhatsApp", "worsening", "MESALMILE", "conditions", "information", "convenience", "inflammation", "sterispharma", "sterisonline", "400mg dosage", "Mesalamine ER", "effectiveness", "multiple doses", "bowel movement", "abdominal pain", "digestive tract", "rectal bleeding", "severe symptoms", "sustained release", "patient compliance", "Regular monitoring", "allergic reactions", "ulcerative colitis", "healthcare provider", "Common side effects", "less frequent dosing", "medication adherence", "effective medication", "Serious side effects", "potential side effects", "follow-up appointments", "anti-inflammatory drug", "administration instructions", "inflammatory bowel diseases", "extended-release formulation", "immediate-release formulations", "consistent therapeutic effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1576, "imageuri": "https://productimages.withfloats.com/actual/667d3a09c134db5b38ba7e15.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3a09c134db5b38ba7e15.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T10:42:48.751Z", "updatedon": "2024-06-28T09:20:38.747Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mesalmile-400/1576", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MESALMILE 400", "category": "GASTROLOGYRANGE", "tags": [ "MESALMILE 400 mg price", "Mesalamine ER (400mg)", "Mesalamine dosage for ulcerative colitis", "Mesalamine side effects", "mesalamine 1.2gm tablets", "mesalamine 1.2gm dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66642e4866170d1ff8cb6484", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LT PRIDE OD 75", "description": "LT PRIDE OD 75\nLevosulpiride sustained release (75mg)\nLT Pride OD 75 is a medication that contains Levosulpiride sustained release (75mg). Levosulpiride is a dopamine receptor antagonist that is used to treat various gastrointestinal and psychiatric disorders. Here are some key points about LT Pride OD 75:\n\nIndications: Levosulpiride is primarily prescribed for conditions such as gastroesophageal reflux disease (GERD), functional dyspepsia, and irritable bowel syndrome (IBS). It helps in relieving symptoms like nausea, vomiting, bloating, and abdominal discomfort.\n\nPsychiatric Uses: In psychiatric practice, Levosulpiride is used to manage certain mood disorders such as depression, anxiety, and dysthymia. It works by modulating dopamine levels in the brain, which can have an impact on mood regulation.\n\nSustained Release Formulation: LT Pride OD 75 is a sustained release formulation, which means that the medication is released gradually over time, providing a more consistent and prolonged effect compared to immediate-release formulations.\n\nDosage: The typical dosage of LT Pride OD 75 is usually determined by the treating healthcare provider based on the patient's condition, age, and other factors. It is important to follow the prescribed dosage and administration instructions carefully.\n\nSide Effects: Common side effects of Levosulpiride may include drowsiness, dizziness, dry mouth, constipation, and changes in appetite. Serious side effects are rare but may include extrapyramidal symptoms (movement disorders), especially at higher doses.\n\nPrecautions: LT Pride OD 75 should be used with caution in patients with a history of neurological disorders, as it may exacerbate certain symptoms. It is not recommended for use in children without proper medical supervision.\n\nConsultation: Patients should consult their healthcare provider before starting or stopping LT Pride OD 75, especially if they are taking other medications or have any underlying medical conditions.\n\nLT Pride OD 75 with Levosulpiride sustained release (75mg) can be an effective treatment option for gastrointestinal and psychiatric disorders when used under medical guidance and supervision.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/lt-pride-od-75-134239\n\n\n\n\n\n\n", "price": 115.0, "discountamount": 35.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "IBS", "Call", "time", "75mg", "GERD", "Email", "brain", "impact", "nausea", "history", "patient", "changes", "anxiety", "WhatsApp", "appetite", "bloating", "children", "vomiting", "dizziness", "dysthymia", "dry mouth", "consistent", "key points", "drowsiness", "depression", "Indications", "Precautions", "information", "LT PRIDE OD", "Consultation", "sterisonline", "sterispharma", "constipation", "higher doses", "other factors", "typical dosage", "mood disorders", "mood regulation", "dopamine levels", "medical guidance", "prolonged effect", "Psychiatric Uses", "other medications", "movement disorders", "Common side effects", "healthcare provider", "abdominal discomfort", "Serious side effects", "psychiatric practice", "functional dyspepsia", "psychiatric disorders", "neurological disorders", "extrapyramidal symptoms", "various gastrointestinal", "irritable bowel syndrome", "proper medical supervision", "effective treatment option", "administration instructions", "dopamine receptor antagonist", "underlying medical conditions", "Sustained Release Formulation", "immediate-release formulations", "Levosulpiride sustained release", "gastroesophageal reflux disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1571, "imageuri": "https://productimages.withfloats.com/actual/66642e4bcb17fd7b0aaa1c54.png", "tileimageuri": "https://productimages.withfloats.com/tile/66642e4bcb17fd7b0aaa1c54.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T10:11:20.585Z", "updatedon": "2024-06-28T09:28:57.548Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lt-pride-od-75/1571", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LT PRIDE OD 75", "category": "GASTROLOGYRANGE", "tags": [ "LT PRIDE OD 75", "Levosulpiride sustained release (75mg)", "Levosulpiride 25 mg Tablet uses", "Levosulpiride before or after food", "Levosulpiride side effects", "Levosulpiride capsule uses", "Levosulpiride 25mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66642af22bed1f08484d8342", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": " LANSOSTRUM 60", "description": "LANSOSTRUM 60\nDexlansoprazole (MR) (60mg)\nLansostrum 60 contains Dexlansoprazole (MR) in a strength of 60mg. Dexlansoprazole is a proton pump inhibitor (PPI) that works by reducing the amount of acid produced in the stomach. It is commonly prescribed to treat conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and stomach ulcers.\n\nDexlansoprazole (MR) differs from traditional dexlansoprazole formulations in that it is designed to provide extended-release action, maintaining acid suppression over a longer period compared to immediate-release formulations. This extended-release feature allows for once-daily dosing convenience.\n\nLansostrum 60, with Dexlansoprazole (MR) 60mg, helps relieve symptoms such as heartburn, regurgitation, and indigestion associated with GERD. It helps heal and prevent damage to the esophagus caused by stomach acid.\n\nIt's important to take Lansostrum 60 as directed by your healthcare provider. Common side effects may include headache, diarrhea, abdominal pain, and nausea. Serious side effects such as severe allergic reactions or Clostridium difficile-associated diarrhea (CDAD) are rare but should be reported to your doctor immediately if experienced.\n\nAs with any medication, discuss with your doctor about your medical history, other medications you are taking, and any allergies before starting Lansostrum 60 to ensure it is safe and appropriate for .\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/lansostrum-60-133773", "price": 210.0, "discountamount": 63.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "PPI", "60mg", "Call", "GERD", "CDAD", "ORDER", "Email", "doctor", "nausea", "damage", "amount", "headache", "strength", "WhatsApp", "symptoms", "allergies", "heartburn", "esophagus", "conditions", "LANSOSTRUM", "information", "indigestion", "sterispharma", "sterisonline", "stomach acid", "regurgitation", "longer period", "stomach ulcers", "abdominal pain", "medical history", "acid suppression", "other medications", "healthcare provider", "Common side effects", "Dexlansoprazole (MR", "erosive esophagitis", "Serious side effects", "proton pump inhibitor", "extended-release action", "extended-release feature", "daily dosing convenience", "severe allergic reactions", "immediate-release formulations", "gastroesophageal reflux disease", "traditional dexlansoprazole formulations", "Clostridium difficile-associated diarrhea" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1569, "imageuri": "https://productimages.withfloats.com/actual/66642af51a59977b77dffe1c.png", "tileimageuri": "https://productimages.withfloats.com/tile/66642af51a59977b77dffe1c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T09:57:06.613Z", "updatedon": "2024-06-28T09:31:27.591Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/-lansostrum-60/1569", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": " LANSOSTRUM 60", "category": "GASTROLOGYRANGE", "tags": [ "LANSOSTRUM 60", "Dexlansoprazole (MR) (60mg)", "Dexlansoprazole side effects", "Dexlansoprazole 60 mg uses", "Dexlansoprazole 60 mg price", "Dexlansoprazole vs omeprazole" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666429c5db9fdd21801f1ae3", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LANSOSTRUM 30", "description": "LANSOSTRUM 30\nDexlansoprazole (MR) (30mg)\nLansostrum 30 contains Dexlansoprazole (MR) at a strength of 30mg. Dexlansoprazole is a proton pump inhibitor (PPI) that is used to treat conditions related to excessive stomach acid production, such as gastroesophageal reflux disease (GERD), erosive esophagitis, and ulcers.\n\nDexlansoprazole works by reducing the amount of acid produced in the stomach, thus helping to relieve symptoms such as heartburn, acid regurgitation, and stomach pain. It belongs to a class of medications known as PPIs, which are highly effective in managing acid-related disorders.\n\nLansostrum 30 with Dexlansoprazole (MR) 30mg provides sustained relief from acid-related symptoms due to its modified-release formulation. This means that the medication is released gradually over time, providing longer-lasting effects compared to immediate-release formulations.\n\nIt is important to take Lansostrum 30 as prescribed by your healthcare provider. Typically, it is taken once daily, preferably in the morning before breakfast. It may take a few days to experience the full benefits of the medication.\n\nCommon side effects of Dexlansoprazole may include headache, diarrhea, stomach pain, and nausea. Serious side effects are rare but may include severe allergic reactions or changes in bone health with long-term use.\n\nIt is crucial to inform your doctor about any other medications, supplements, or medical conditions you have before starting Lansostrum 30 to avoid potential interactions or complications. Follow your doctor's instructions closely for the best results and to minimize the risk of side effects.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/lansostrum-30-133772\n\n\n\n\n\n\n", "price": 145.0, "discountamount": 44.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "PPI", "GERD", "time", "risk", "days", "30mg", "class", "Email", "ulcers", "doctor", "amount", "nausea", "morning", "changes", "headache", "diarrhea", "strength", "WhatsApp", "breakfast", "heartburn", "LANSOSTRUM", "bone health", "information", "supplements", "sterispharma", "instructions", "sterisonline", "best results", "stomach pain", "complications", "long-term use", "full benefits", "sustained relief", "other medications", "medical conditions", "acid regurgitation", "erosive esophagitis", "release formulation", "healthcare provider", "Dexlansoprazole (MR", "Common side effects", "Serious side effects", "proton pump inhibitor", "acid-related symptoms", "acid-related disorders", "potential interactions", "severe allergic reactions", "gastroesophageal reflux disease", "excessive stomach acid production" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1568, "imageuri": "https://productimages.withfloats.com/actual/666429c72763378392d53d51.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666429c72763378392d53d51.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T09:52:05.21Z", "updatedon": "2024-06-28T09:32:46.37Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lansostrum-30/1568", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LANSOSTRUM 30", "category": "GASTROLOGYRANGE", "tags": [ "LANSOSTRUM 30", "Dexlansoprazole (MR) (30mg)", "Dexlansoprazole side effects", "Dexlansoprazole 60 mg price", "Dexlansoprazole 60 mg uses", "Dexlansoprazole MR capsules 60 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662b5587de2b5203089e01d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE M 850 ", "description": "VILDIABATE M 850 \nMetformin (850mg)SR, Vildagliptin (50mg)\nIntroduction to VILDIABATE M 850\nVILDIABATE M 850 is a combination medication designed to manage type 2 diabetes mellitus effectively. It combines Metformin Hydrochloride Sustained Release (SR) 850mg and Vildagliptin 50mg. This dual-action formulation targets different pathways involved in glucose regulation, providing comprehensive blood sugar control. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Components and Their Mechanisms\nMetformin SR 850mg\nMetformin is a biguanide that helps lower blood sugar levels through several mechanisms:\n\nReduces Hepatic Glucose Production: Metformin decreases the amount of glucose produced by the liver.\nImproves Insulin Sensitivity: It enhances the sensitivity of muscle cells to insulin, promoting better glucose uptake and utilization.\nDecreases Intestinal Absorption of Glucose: Metformin reduces the absorption of glucose from the gastrointestinal tract.\nThe sustained-release (SR) formulation ensures a gradual release of the medication, providing prolonged therapeutic effects and reducing the risk of gastrointestinal side effects.\n\nVildagliptin 50mg\nVildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by:\n\nEnhancing Incretin Levels: Vildagliptin inhibits the DPP-4 enzyme, which degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones increase insulin secretion and decrease glucagon release in a glucose-dependent manner.\nImproving Postprandial Glucose Control: By enhancing the action of incretin hormones, Vildagliptin helps regulate blood sugar levels after meals.\nBenefits of VILDIABATE M 850\nComprehensive Blood Sugar Control\nFasting and Postprandial Glucose Management: The combination of Metformin SR and Vildagliptin effectively manages both fasting and postprandial (after-meal) blood sugar levels.\nImproved Insulin Sensitivity and Secretion: Metformin improves insulin sensitivity, while Vildagliptin enhances insulin secretion in response to meals.\nExtended Release Formulation\nProlonged Effect: The sustained-release formulation of Metformin ensures a steady release of the medication, providing long-lasting blood sugar control and minimizing peaks and troughs in blood sugar levels.\nReduced Gastrointestinal Side Effects: The gradual release of Metformin helps reduce common gastrointestinal side effects associated with immediate-release formulations.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: This combination is generally weight-neutral, making it a suitable option for patients concerned about weight gain.\nDosage and Administration\nRecommended Dosage\nDosage: The typical dosage is one tablet taken once or twice daily, preferably with a meal to reduce gastrointestinal side effects.\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your healthcare provider.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE M 850 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-m-850-133455", "price": 299.0, "discountamount": 89.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "diet", "Order", "EMAIL", "water", "glass", "liver", "GLP-1", "peaks", "meals", "adults", "amount", "option", "troughs", "Fasting", "exercise", "Low Risk", "patients", "readings", "response", "Enhancing", "same time", "biguanide", "Guidelines", "one tablet", "weight gain", "Optimal Use", "information", "Adjustments", "utilization", "Vildagliptin", "Metformin SR", "sterispharma", "Hypoglycemia", "Introduction", "best results", "sterisonline", "DPP-4 enzyme", "muscle cells", "CALL/WHATSAPP", "treatment plan", "glucose uptake", "steady release", "typical dosage", "Key Components", "Administration", "Weight Neutral", "Consistent Use", "low blood sugar", "Incretin Levels", "gradual release", "glycemic control", "VILDIABATE M 850", "glucagon release", "Prolonged Effect", "DPP-4) inhibitor", "incretin hormones", "insulin secretion", "glucose regulation", "several mechanisms", "different pathways", "Regular monitoring", "healthcare provider", "Insulin Sensitivity", "blood glucose levels", "Intestinal Absorption", "combination medication", "dipeptidyl peptidase-4", "gastrointestinal tract", "dual-action formulation", "meal) blood sugar levels", "type 2 diabetes mellitus", "glucose-dependent manner", "Recommended Dosage Dosage", "Additional Health Benefits", "Hepatic Glucose Production", "Extended Release Formulation", "sustained-release formulation", "prolonged therapeutic effects", "immediate-release formulations", "Postprandial Glucose Management", "long-lasting blood sugar control", "comprehensive blood sugar control", "sustained-release (SR) formulation", "common gastrointestinal side effects", "Reduced Gastrointestinal Side Effects", "Improving Postprandial Glucose Control", "glucose-dependent insulinotropic peptide", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1504, "imageuri": "https://productimages.withfloats.com/actual/667d44a2576e8da931df856b.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d44a2576e8da931df856b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T07:23:04.367Z", "updatedon": "2024-06-27T10:53:21.595Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-m-850-/1504", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE M 850 ", "category": "DIABETIC RANGE", "tags": [ "vildagliptin metformin 50/850 price", "vildagliptin and metformin hydrochloride tablets s" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662b1e6870e7b20c49e6522", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE M 500 ", "description": "VILDIABATE M 500 \nMetformin (500mg)SR, Vildagliptin (50mg)\nIntroduction to VILDIABATE M 500\nVILDIABATE M 500 is a combination medication designed to manage type 2 diabetes mellitus effectively. It contains Metformin Hydrochloride Sustained Release (SR) 500mg and Vildagliptin 50mg. This dual-action formula targets different pathways involved in glucose regulation to provide comprehensive blood sugar control. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Components and Their Mechanisms\nMetformin SR 500mg\nMetformin is a biguanide that helps lower blood sugar levels through several mechanisms:\n\nReduces Hepatic Glucose Production: Metformin decreases the amount of glucose produced by the liver.\nImproves Insulin Sensitivity: It enhances the sensitivity of muscle cells to insulin, promoting better glucose uptake and utilization.\nDecreases Intestinal Absorption of Glucose: Metformin reduces the absorption of glucose from the gastrointestinal tract.\nThe sustained-release (SR) formulation ensures a gradual release of the medication, providing prolonged therapeutic effects and reducing the risk of gastrointestinal side effects.\n\nVildagliptin 50mg\nVildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by:\n\nEnhancing Incretin Levels: Vildagliptin inhibits the DPP-4 enzyme, which degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones increase insulin secretion and decrease glucagon release in a glucose-dependent manner.\nImproving Postprandial Glucose Control: By enhancing the action of incretin hormones, Vildagliptin helps regulate blood sugar levels after meals.\nBenefits of VILDIABATE M 500\nComprehensive Blood Sugar Control\nFasting and Postprandial Glucose Management: The combination of Metformin SR and Vildagliptin effectively manages both fasting and postprandial (after-meal) blood sugar levels.\nImproved Insulin Sensitivity and Secretion: Metformin improves insulin sensitivity, while Vildagliptin enhances insulin secretion in response to meals.\nExtended Release Formulation\nProlonged Effect: The sustained-release formulation of Metformin ensures a steady release of the medication, providing long-lasting blood sugar control and minimizing peaks and troughs in blood sugar levels.\nReduced Gastrointestinal Side Effects: The gradual release of Metformin helps reduce common gastrointestinal side effects associated with immediate-release formulations.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: This combination is generally weight-neutral, making it a suitable option for patients concerned about weight gain.\nDosage and Administration\nRecommended Dosage\nDosage: The typical dosage is one tablet taken once or twice daily, preferably with a meal to reduce gastrointestinal side effects.\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your healthcare provider.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE M 500 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-m-500-133454", "price": 289.0, "discountamount": 86.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "diet", "Order", "EMAIL", "water", "glass", "liver", "GLP-1", "peaks", "meals", "adults", "amount", "option", "troughs", "Fasting", "exercise", "Low Risk", "patients", "readings", "response", "Enhancing", "same time", "biguanide", "Guidelines", "one tablet", "weight gain", "Optimal Use", "information", "Adjustments", "utilization", "Vildagliptin", "Metformin SR", "sterispharma", "Hypoglycemia", "Introduction", "best results", "sterisonline", "DPP-4 enzyme", "muscle cells", "CALL/WHATSAPP", "glucose uptake", "steady release", "typical dosage", "Key Components", "treatment plan", "Weight Neutral", "Consistent Use", "Administration", "Incretin Levels", "gradual release", "low blood sugar", "glycemic control", "DPP-4) inhibitor", "VILDIABATE M 500", "glucagon release", "Prolonged Effect", "incretin hormones", "insulin secretion", "several mechanisms", "different pathways", "Regular monitoring", "glucose regulation", "dual-action formula", "Insulin Sensitivity", "healthcare provider", "blood glucose levels", "Intestinal Absorption", "combination medication", "gastrointestinal tract", "dipeptidyl peptidase-4", "type 2 diabetes mellitus", "glucose-dependent manner", "meal) blood sugar levels", "Recommended Dosage Dosage", "Additional Health Benefits", "Hepatic Glucose Production", "Extended Release Formulation", "sustained-release formulation", "prolonged therapeutic effects", "immediate-release formulations", "Postprandial Glucose Management", "long-lasting blood sugar control", "comprehensive blood sugar control", "sustained-release (SR) formulation", "common gastrointestinal side effects", "Reduced Gastrointestinal Side Effects", "Improving Postprandial Glucose Control", "glucose-dependent insulinotropic peptide", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1499, "imageuri": "https://productimages.withfloats.com/actual/667d4af8b567218985111efd.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d4af8b567218985111efd.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T07:08:22.623Z", "updatedon": "2024-06-27T11:20:23.412Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-m-500-/1499", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE M 500 ", "category": "DIABETIC RANGE", "tags": [ "vildagliptin metformin 50/1000", "vildagliptin metformin 50/500 price", "ildagliptin and metformin hydrochloride tablets si" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662af26db100e1fdc2dcc17", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE M 1000 ", "description": "VILDIABATE M 1000 \nMetformin (1000mg)SR, Vildagliptin (50mg)\nIntroduction to VILDIABATE M 1000\nVILDIABATE M 1000 is a combination medication designed for the effective management of type 2 diabetes mellitus. It contains Metformin Hydrochloride Sustained Release (SR) 1000mg and Vildagliptin 50mg. This dual-action formula targets different pathways involved in glucose regulation to provide comprehensive blood sugar control. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Components and Their Mechanisms\nMetformin SR 1000mg\nMetformin is a biguanide that helps lower blood sugar levels through several mechanisms:\n\nReduces Hepatic Glucose Production: Metformin decreases the amount of glucose produced by the liver.\nImproves Insulin Sensitivity: It enhances the sensitivity of muscle cells to insulin, promoting better glucose uptake and utilization.\nDecreases Intestinal Absorption of Glucose: Metformin reduces the absorption of glucose from the gastrointestinal tract.\nThe sustained release (SR) formulation ensures a gradual release of the medication, providing prolonged therapeutic effects and reducing the risk of gastrointestinal side effects.\n\nVildagliptin 50mg\nVildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by:\n\nEnhancing Incretin Levels: Vildagliptin inhibits the DPP-4 enzyme, which degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones increase insulin secretion and decrease glucagon release in a glucose-dependent manner.\nImproving Postprandial Glucose Control: By enhancing the action of incretin hormones, Vildagliptin helps regulate blood sugar levels after meals.\nBenefits of VILDIABATE M 1000\nComprehensive Blood Sugar Control\nFasting and Postprandial Glucose Management: The combination of Metformin SR and Vildagliptin effectively manages both fasting and postprandial (after-meal) blood sugar levels.\nImproved Insulin Sensitivity and Secretion: Metformin improves insulin sensitivity, while Vildagliptin enhances insulin secretion in response to meals.\nExtended Release Formulation\nProlonged Effect: The sustained-release formulation of Metformin ensures a steady release of the medication, providing long-lasting blood sugar control and minimizing peaks and troughs in blood sugar levels.\nReduced Gastrointestinal Side Effects: The gradual release of Metformin helps reduce common gastrointestinal side effects associated with immediate-release formulations.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin, in particular, has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: This combination is generally weight neutral, making it a suitable option for patients concerned about weight gain.\nDosage and Administration\nRecommended Dosage\nDosage: The typical dosage is one tablet taken once daily, preferably with a meal to reduce gastrointestinal side effects.\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your healthcare provider.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE M 1000 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-m-1000-133453", "price": 319.0, "discountamount": 95.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "diet", "GLP-1", "Order", "EMAIL", "water", "glass", "liver", "peaks", "meals", "adults", "amount", "option", "troughs", "Fasting", "exercise", "Low Risk", "patients", "response", "readings", "same time", "Enhancing", "biguanide", "one tablet", "Guidelines", "Optimal Use", "information", "utilization", "weight gain", "Adjustments", "Introduction", "Vildagliptin", "Metformin SR", "VILDIABATE M", "sterispharma", "best results", "Hypoglycemia", "sterisonline", "DPP-4 enzyme", "muscle cells", "CALL/WHATSAPP", "Weight Neutral", "Consistent Use", "Administration", "treatment plan", "steady release", "typical dosage", "Key Components", "glucose uptake", "low blood sugar", "Incretin Levels", "gradual release", "SR) formulation", "glucagon release", "glycemic control", "Prolonged Effect", "DPP-4) inhibitor", "insulin secretion", "incretin hormones", "several mechanisms", "different pathways", "glucose regulation", "Regular monitoring", "dual-action formula", "healthcare provider", "Insulin Sensitivity", "blood glucose levels", "effective management", "Intestinal Absorption", "gastrointestinal tract", "combination medication", "dipeptidyl peptidase-4", "type 2 diabetes mellitus", "glucose-dependent manner", "meal) blood sugar levels", "Recommended Dosage Dosage", "Additional Health Benefits", "Hepatic Glucose Production", "Extended Release Formulation", "sustained-release formulation", "prolonged therapeutic effects", "immediate-release formulations", "Postprandial Glucose Management", "long-lasting blood sugar control", "comprehensive blood sugar control", "common gastrointestinal side effects", "Reduced Gastrointestinal Side Effects", "Improving Postprandial Glucose Control", "glucose-dependent insulinotropic peptide", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1496, "imageuri": "https://productimages.withfloats.com/actual/6662af29d878d473a9fda03d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662af29d878d473a9fda03d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T06:56:38.67Z", "updatedon": "2024-06-28T11:39:06.99Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-m-1000-/1496", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE M 1000 ", "category": "DIABETIC RANGE", "tags": [ "VILDIABATE M 1000", "Metformin (1000mg)SR", "Vildagliptin (50mg)", "Vildagliptin 50mg side effects", "Vildagliptin tablets 50 mg uses", "Vildagliptin 50 mg price", "Vildagliptin 50 mg and metformin 500 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }